BioPharma Conference

Posted By Michael J. Burke, Friday, September 25, 2020 “It’s clear that over the last eight, nine months things have changed significantly. There really is no going back. The status quo is no more. Everything that has been done in the past can, and in many instances must, be... Continue Reading

“Humanity Is Relying on You!” Ed Cox Tells BioPharma Conference Attendees to Embrace the Challenge of Ending the Pandemic Posted By Jon Lavietes, Thursday, September 17, 2020 Ed Cox, executive vice president of strategic alliances and global head of digital medicine at EVERSANA, was... Continue Reading

Posted By Michael J. Burke, Thursday, September 17, 2020 Melinda Richter’s journey began very humbly, in a small wooden house with no running water in northern Canada. Growing up in that harsh environment with her parents and seven siblings wasn’t easy, especially in winter. But she... Continue Reading

Posted By Michael J. Burke, Wednesday, September 16, 2020 There are many things biopharma alliance professionals do well, and many areas where they shine. Partnerships between life sciences companies and digital organizations, however, while on the rise, remain the new frontier for alliance... Continue Reading

Posted By Jon Lavietes, Tuesday, September 15, 2020 As alliance managers, it is sometimes easy to get bogged down in the operational and administrative parts of collaborations—structuring governance, disseminating minutes of meetings, administering health checks, and the like. However, we... Continue Reading

“A Mindset, Not a Department”: BioPharma Conference Begins with a Vision of Alliance Management Excellence Posted By Michael J. Burke, Tuesday, September 15, 2020 Day one of the virtual 2020 ASAP BioPharma Conference featured speakers sharing a vision of alliance management in the... Continue Reading

Updated: Friday, September 27, 2019 Andre Turenne began his Wednesday keynote address at the 2019 ASAP BioPharma Conference , held Sept. 23­–25 in Boston, by reminding everyone why biopharma companies form partnerships in the first place: to more effectively find and create new... Continue Reading

“We see at the highest levels of business and government what happens when we don’t maintain and preserve alliances.” Such was the plain, blunt statement of Rob Bazemore, president and CEO of Epizyme, Inc., Tuesday’s keynote speaker at the 2019 ASAP BioPharma Conference,... Continue Reading

Perhaps one of the less appreciated and less understood roles in biopharma alliances—particularly codevelopment, cocommercial alliances—is that of the medical affairs team, specifically medical science liaisons (MSLs). These field-level folks implement a medical affairs plan and... Continue Reading

Nontraditional alliances took center stage (literally) yet again today as the opening session at the ASAP BioPharma Conference 2019 got under way in Boston. Titled “Building Value in Non-Traditional Pharma/Biotech Partnerships: BMS and Concerto Health AI,” the session was moderated by... Continue Reading

Even a year or two ago, the idea of digital therapeutics didn’t stir up a great amount of interest among most participants at ASAP’s BioPharma Conference, according to Mike Leonetti, president and CEO of ASAP. That sort of ambivalence no longer applies, as was evident at the September... Continue Reading